We tried to find the relationship between risk score and patients’ clinical information, and found that patients’ age, glioma grade and survival status, cluster and immune score were positively correlated with risk score, Moreover, the risk score calculated by our formula can identify the survival probability of patients with different clinical features including grade, IDH and 1p19q1 status. This evidence concerns the gene IDH2 and central nervous system cancer.